UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

AMD 3100 for Treatment of Myelokathexis

Phase 1

Completed

Conditions: Neutropenia

Interventions: Drug: AMD3100 or plerixafor

First Posted Date: 2010-01-29

Last Posted Date: 2012-06-15

Lead Sponsor: University of Washington

Target Recruit Count: 6

Registration Number: NCT01058993

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

Not Applicable

Withdrawn

Conditions: HIV
HIV Infections

First Posted Date: 2010-01-29

Last Posted Date: 2012-12-05

Lead Sponsor: University of Washington

Registration Number: NCT01059084

Study of Treatments Used for White Spot Lesions After Orthodontic Treatment.

Not Applicable

Completed

Conditions: Tooth Demineralization

Interventions: Procedure: MI Paste Plus
Procedure: PreviDent Fluoride Varnish
Procedure: Normal Home Care

First Posted Date: 2010-01-29

Last Posted Date: 2015-08-17

Lead Sponsor: University of Washington

Target Recruit Count: 240

Registration Number: NCT01059058

Locations: 🇺🇸
University of Washington/NW PRECEDENT, Seattle, Washington, United States

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Recruiting

Conditions: Malignant Solid Neoplasm
Recurrent Bladder Carcinoma
Stage IV Bladder Cancer AJCC v7
Stage IV Bladder Urothelial Carcinoma AJCC v7
Stage IV Prostate Cancer AJCC v7
Localized Renal Pelvis and Ureter Urothelial Carcinoma
Metastatic Malignant Neoplasm in the Soft Tissues
Metastatic Renal Pelvis and Ureter Urothelial Carcinoma
Recurrent Prostate Carcinoma
Recurrent Renal Pelvis and Ureter Urothelial Carcinoma

Interventions: Other: Cytology Specimen Collection Procedure
Other: Laboratory Biomarker Analysis

First Posted Date: 2010-01-15

Last Posted Date: 2024-07-19

Lead Sponsor: University of Washington

Target Recruit Count: 1500

Registration Number: NCT01050504

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

MOMCare: Culturally Relevant Treatment Services for Perinatal Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: MOMCare

First Posted Date: 2010-01-11

Last Posted Date: 2016-01-15

Lead Sponsor: University of Washington

Target Recruit Count: 168

Registration Number: NCT01045655

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Memantine for Post-Operative Pain Control

Phase 4

Conditions: Pain, Post-operative

Interventions: Drug: Memantine
Drug: Placebo

First Posted Date: 2009-12-31

Last Posted Date: 2010-06-29

Lead Sponsor: University of Washington

Target Recruit Count: 120

Registration Number: NCT01041313

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Adjustable Gastric Band Survey Study

Withdrawn

Conditions: Morbid Obesity

Interventions: Other: Survey

First Posted Date: 2009-12-31

Last Posted Date: 2022-12-13

Lead Sponsor: University of Washington

Registration Number: NCT01041534

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Local Warming of Surgical Incisions

Phase 3

Completed

Conditions: Surgical Wound Infection

Interventions: Other: Warming of surgical incision
Other: Warming dressing without actual warming

First Posted Date: 2009-12-04

Last Posted Date: 2009-12-04

Lead Sponsor: University of Washington

Target Recruit Count: 146

Registration Number: NCT01026259

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Novel Immune Markers in Patients With Multiple Sclerosis

Conditions: Multiple Sclerosis

First Posted Date: 2009-12-04

Last Posted Date: 2010-07-13

Lead Sponsor: University of Washington

Target Recruit Count: 120

Registration Number: NCT01026272

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

Phase 4

Completed

Conditions: HSV Infection
HIV Infection

Interventions: Drug: acyclovir
Drug: valacyclovir

First Posted Date: 2009-12-04

Last Posted Date: 2014-04-08

Lead Sponsor: University of Washington

Target Recruit Count: 32

Registration Number: NCT01026454

Locations: 🇰🇪
Thika Partners in Prevention, Thika, Kenya

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy